The aim of this study is to investigate the expression levels and clinical significance of ILF2
in gastric cancer. The mRNA and protein expression levels of ILF2 were, respectively …

Interleukin enhancer‑binding factor 3 (ILF3) may function as a transcriptional coactivator and
has been reported to be involved in tumor proliferation and metastasis; however, its role and …

Purpose The interferon regulatory factor 2 (IRF-2) acted as a tumor suppressor. We
inspected IRF-2 as a predictor of prognosis in gastric cancer (GC) patients and tried to find …

Abstract Interferon regulatory factor 2 (IRF-2) is known to play a pivotal role in the
development and progression of several malignancies. As a crucial member of interferon …

Background Stomach adenocarcinoma (STAD) is one of the most prevalent malignances,
ranking fifth in incidence and third in mortality among all malignances. Interferon regulatory …

Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods This study …

Insulin gene enhancer binding protein–1 (ISL-1) is a transcription factor involved in
development of the heart, motor neurons, and pancreas. Our previous study indicated that …

Background Gastric cancer (GC) lacks serum biomarkers with clinical diagnostic value. Multi-
omics analysis is an important approach to discovering cancer biomarkers. This study aimed …

Background/Aims: The status of interferon (IFN) signaling pathway has been shown to be
closely associated with the response of immune checkpoint blockade therapy against …

The worldwide mortality rate of gastric cancer worldwide remains high. Immunoglobulin-like
domain containing receptor 1 (ILDR1) belongs to an evolutionarily conserved protein family …